Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, J. D.
Right arrow Articles by Brown, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, J. D.
Right arrow Articles by Brown, M. L.
Mol Cancer Ther. 2003;2:1149-1154
© 2003 American Association for Cancer Research

Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3

James D. Anderson1, Todd P. Hansen1, Paul W. Lenkowski1, Alison M. Walls3, Indrani M. Choudhury1, Hilary A. Schenck1, Mati Friehling1, Genevieve M. Höll1, Manoj K. Patel2, Robert A. Sikes3 and Milton L. Brown1

1 Departments of Chemistry and 2 Anesthesiology, University of Virginia, Charlottesville, VA, and 3 Department of Biological Sciences, University of Delaware, Newark, DE

Requests for Reprints:Milton L. Brown, Department of Chemistry, University of Virginia, McCormick Road, P. O. Box 400319, Charlottesville, VA 22904. Phone: (434) 982-3091; Fax: (434) 924-0798. E-mail: mlb2v{at}virginia.edu

The recent discovery of sodium (Na+) channel expression in human prostate cancer (PCa) cells led us to investigate the potential use of neuronal Na+ channel blockers as inhibitors of PCa cells. Our initial studies discovered two classes of Na+ channel blockers that were effective inhibitors of PCa cell proliferation. Both hydroxyamides (compounds 1 and 4) and a hydantoin (compound 5) were shown to inhibit the androgen-independent PCa cell line PC-3 in vitro. Electrophysiology showed that all compounds functionally block brain type II voltage-gated Na+ channels (Nav1.2) expressed in Xenopus laevis oocytes. Long-term growth assays in androgen-independent PC-3 cells showed remarkable inhibition of cell growth, with cells growing to a maximum of 30% of controls with analogue 1. Further, our analogues demonstrated only marginal impact on cell viability over the same treatment interval.


The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Grant support:Jeffress Trust (M. L. B.), Paul Mellon Fund (M. L. B.), and University of Virginia Burger Center for Biological Sciences (M. L. B.). Additional funding from University of Delaware Research Foundation (R. A. S.) and Department of Biological Sciences, University of Delaware (R. A. S.).

Received 1/ 8/03; revised 8/19/03; accepted 8/28/03.




This article has been cited by other articles:


Home page
J. Physiol.Home page
W. J. Brackenbury and M. B. A. Djamgoz
Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line
J. Physiol., June 1, 2006; 573(2): 343 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.